HedgeCo.Net — Thoma Bravo agreed Thursday to take Accelerant Holdings private in an all-cash transaction with an enterprise value of more than $4 billion, paying $20.25 a share — a 49% premium to Wednesday’s close — and ending a public listing that had lasted little more than a year. For private-equity allocators, the deal is less a trophy software buyout than a test of whether specialty-insurance “risk exchange” platforms belong in the same underwriting box as core vertical software, and whether a 49% premium is the price of taking that thesis off the public tape.
Accelerant, which operates a data-driven marketplace connecting specialty underwriters with risk capital, said a special committee of independent directors unanimously recommended the merger and that the full board approved it. Entities affiliated with Altamont Capital Partners, holding about 82% of outstanding voting rights, have agreed to vote in favor. Altamont and the company’s founders intend to retain equity alongside Thoma Bravo, whose equity commitment means the transaction is not subject to a financing condition. Closing is expected in the first half of 2027, subject to shareholder and insurance-regulatory approvals. If specified regulatory delays push the timetable, shareholders receive a ticking fee accruing at 6% per annum — a contractual admission that insurance commissioners, not lenders, are the gating item.
That structure matters for LPs. A 1H 2027 close on a 2026 signing is a long gap even by financial-sponsor standards, and it embeds duration risk in a sector where capital, licenses, and data-sharing arrangements all sit inside regulated entities. Reuters noted Accelerant’s shares had traded well below the $21 IPO price before the bid; they jumped about 44% in Thursday trading and closed at $19.51, still below the cash consideration, a classic merger-arb spread that prices residual deal risk. Thoma Bravo, which reported more than $172 billion of AUM as of March 31, 2026, has spent years assembling insurance-technology and data assets, including Nearmap’s acquisition of claims specialist itel for more than $1.3 billion. Accelerant is a different animal: a platform whose value is the two-sided exchange, not a point-solution SaaS contract.
Second-order implications run in two directions. For software PE, the deal is another data point that public-market multiples on recently listed vertical platforms can disconnect from sponsor underwriting, creating take-private entry points even after a recent IPO. For insurance and alternatives allocators who sit on the “buyer” side of Accelerant’s exchange, a Thoma Bravo-controlled, recapitalized platform with more technology and capital capacity could become a more important origination rail — or a more concentrated counterparty. The 6% ticking fee and Altamont rollover are the tells: this is a control deal designed to survive a long regulatory slog, not a quick recap. LPs should underwrite the close date, not the press-release premium.